2 terminated. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Terminated 2 |
Follow Endothelial Dysfunction: new trials by email Literature Review of Endothelial Dysfunction trials Research Report on Endothelial Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes Dapagliflozin, Placebo - Diabetes Mellitus, Type 2, Endothelial Dysfunction | Phase 4 | Terminated | Boston University | 4 | 2022-05-31 | 2026-02-11 |
| Endothelial Protection in Convalescent COVID-19 Patients Sulodexide - Endothelial Dysfunction, Inflammation | Phase 4 | Terminated | Pirogov Russian National Research Medical University | 2 | 2022-04-01 | 2025-06-13 |
COVID-19 (1) · Diabetes Mellitus, Type 2 (1) · Inflammation (1) · Thrombosis (1)
Cardiovascular Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Diabetes Mellitus (1) · Embolism and Thrombosis (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Infections (1) · Lung Diseases (1) · Metabolic Diseases (1) · Nidovirales Infections (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Pneumonia (1)
dapagliflozin (1) · glucuronyl glucosamine glycan sulfate (1)
Boston University (1) · Pirogov Russian National Research Medical University (1)
Russia (1) · United States (1)
Kirill Lobastov, PhD (1) · Naomi M Hamburg, MD (1)